德康醫療

63.30
Open
61.60
Market Cap
23.95B+
High
62.86
Low
60.57
Close
62.22
Volume
2.41M+
P/E Ratio
29.77
Div/Yield
0.00%

About 德康醫療

DexCom, Inc. 是一家醫療設備公司,專注於美國和國際上連續血糖監測 (CGM) 系統的設計、開發和商業化。該公司提供其係統供糖尿病患者使用,也供醫療保健提供者使用。其產品包括用於糖尿病管理的集成 CGM 系統 DexCom G6; Dexcom 實時 API,使受邀的第三方開發人員能夠將實時 CGM 數據集成到他們的數字健康應用程序和設備中; Dexcom ONE,旨在取代用於糖尿病治療決策的指尖血糖測試;和遠程監控系統 Dexcom Share。該公司的候選產品包括下一代 G7 CGM 系統 Dexcom G7。 DexCom , Inc .與 Verily Life Sciences LLC 和 Verily Ireland Limited 簽訂了合作和許可協議,以開發基於血液或間質的葡萄糖監測產品。該公司直接向內分泌學家、醫生和糖尿病教育工作者銷售其產品。 DexCom, Inc.成立於1999年,總部位於加利福尼亞州聖地亞哥。

如何購買 德康醫療 (DXCM)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 DXCM

購買 DXCM

透過 RockFlow App 或網頁端搜尋 DXCM,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.